We reach more than 65,000 registered users in Dec!!

Lab tests of e-cigarettes demonstrate cellular harm

Preclinical data based on experiments in mice suggest the promise of a novel drug directed against a novel target in malignant mammary tumors. The work excites researchers because in mouse models of human metastatic breast cancer, it has produced 'differentiation of an aggressive primary tumor, redirecting it from a highly proliferative state, and reducing its metastatic activity by 70 percent.' Both the drug and its target are nucleic acids.

Leave a comment

Search Similar Posts

    No tags found for this post